US Stock MarketDetailed Quotes

IDYA IDEAYA Biosciences

Watchlist
  • 25.610
  • +0.820+3.31%
Close Dec 20 16:00 ET
  • 25.610
  • 0.0000.00%
Post 20:01 ET
2.21BMarket Cap-10.99P/E (TTM)

About IDEAYA Biosciences Company

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Company Profile

SymbolIDYA
Company NameIDEAYA Biosciences
Listing DateMay 23, 2019
Issue Price10.00
Founded2015
CEOMr. Yujiro S. Hata
MarketNASDAQ
Employees124
Fiscal Year Ends12-31
Address5000 Shoreline Court,Suite 300
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-443-6209
Websitehttp://www.ideayabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Yujiro S. Hata
  • Director, President and Chief Executive Officer
  • 6.00M
  • Dr. Michael Anthony White, PhD
  • Chief Scientific Officer
  • 2.76M
  • Dr. Darrin M. Beaupre, M.D.
  • Chief Medical Officer
  • 1.81M
  • Andres Ruiz Briseno
  • Principal Financial Officer, Principal Accounting Officer, Senior Vice President, Head of Finance and Investor Relations
  • 1.41M
  • Dr. Terry Rosen, PhD
  • Chairman of the Board
  • 369.52K
  • Malcolm Garret Hampton, PhD
  • Independent Director
  • 349.52K
  • Dr. Jeffrey Stein, PhD
  • Independent Director
  • 363.02K
  • Dr. Catherine J. Mackey, PhD
  • Independent Director
  • 350.52K
  • Wendy L. Yarno, M.B.A.
  • Independent Director
  • 358.02K
  • Scott W. Morrison
  • Independent Director
  • 364.52K
  • Dr. Susan L. Kelley, M.D.
  • Independent Director
  • 349.52K
Heat List
US
Overall
Symbol
Price
% Chg

No Data